VANGUARD GROUP INC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,034,651
-49.2%
5,476,744
+2.2%
0.00%
-100.0%
Q2 2023$25,660,906
-22.7%
5,357,183
-8.5%
0.00%0.0%
Q1 2023$33,187,281
-2.7%
5,853,136
-3.9%
0.00%0.0%
Q4 2022$34,120,448
-19.6%
6,092,937
-7.8%
0.00%0.0%
Q3 2022$42,442,000
+132.1%
6,610,856
+24.0%
0.00%0.0%
Q2 2022$18,285,000
-49.3%
5,330,817
+5.2%
0.00%0.0%
Q1 2022$36,076,000
-7.4%
5,066,930
+8.4%
0.00%0.0%
Q4 2021$38,953,000
+41.5%
4,676,265
+18.2%
0.00%0.0%
Q3 2021$27,535,000
-66.1%
3,956,272
+16.2%
0.00%
-50.0%
Q2 2021$81,223,000
+15.4%
3,405,570
-0.4%
0.00%0.0%
Q1 2021$70,403,000
-9.3%
3,419,277
+8.0%
0.00%0.0%
Q4 2020$77,599,000
-0.5%
3,167,319
+15.0%
0.00%
-33.3%
Q3 2020$78,004,000
+625.8%
2,755,345
+22.0%
0.00%
Q2 2020$10,748,000
+39.7%
2,257,979
+4.8%
0.00%
Q1 2020$7,694,000
+4.2%
2,155,156
+0.7%
0.00%
Q4 2019$7,382,000
-12.0%
2,139,641
+2.3%
0.00%
Q3 2019$8,390,000
+26.5%
2,092,286
+1.6%
0.00%
Q2 2019$6,635,000
+7.2%
2,060,327
+128.7%
0.00%
Q1 2019$6,191,000
+61.0%
901,032
+5.9%
0.00%
Q4 2018$3,846,000
-50.8%
850,846
-17.4%
0.00%
Q3 2018$7,815,000
-35.8%
1,029,643
-27.3%
0.00%
-100.0%
Q2 2018$12,180,000
-3.3%
1,416,254
-17.5%
0.00%0.0%
Q1 2018$12,596,000
-20.1%
1,716,067
+10.4%
0.00%0.0%
Q4 2017$15,762,000
-40.9%
1,554,567
-6.5%
0.00%0.0%
Q3 2017$26,681,000
+49.0%
1,663,373
+4.9%
0.00%0.0%
Q2 2017$17,911,000
+1.5%
1,585,026
+1.2%
0.00%0.0%
Q1 2017$17,645,000
+21.9%
1,565,663
+7.1%
0.00%0.0%
Q4 2016$14,476,000
-12.6%
1,462,207
+8.5%
0.00%0.0%
Q3 2016$16,558,000
-51.6%
1,347,194
+14.5%
0.00%
-50.0%
Q2 2016$34,191,000
+35.9%
1,176,924
+24.3%
0.00%0.0%
Q1 2016$25,151,000
+31.6%
946,954
+73.8%
0.00%
+100.0%
Q4 2015$19,115,000
+34.3%
544,752
+13.5%
0.00%0.0%
Q3 2015$14,232,000
+1614.7%
480,165
+2300.8%
0.00%
Q2 2015$830,00020,0000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders